Lanean...
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is then reintroduced into the patient’s body to fight the...
Gorde:
| Argitaratua izan da: | J Clin Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7019711/ https://ncbi.nlm.nih.gov/pubmed/31936611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9010182 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|